Specialised Therapeutics

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • ST Asia
  • Specialised Therapeutics Asia Pte Ltd
  • Specialised Therapeutics Asia
See more in Biomedtracker

Latest on Specialised Therapeutics

Scrip

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Xu Hu

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. SunRock, Escugen Partner To Develo

Scrip

Asia Deal Watch: Maruho Licenses Rights In Japan To GI Innovation’s Allergy Candidate

 
• By Jung Won Shin, Vibha Ravi, Lisa Takagi, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Maruho Obtains Rights To GI-301 No

Scrip

Deal Watch: Novo Nordisk Builds On Metabolic Strength Acquiring Partner Embark

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk Brings Embark Home After F

Scrip

Deal Watch: Japan’s SNBL To Re-Absorb US Spinout Satsuma

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. SNBL To Pay 28% Premium To Re-Acquire S